Novel Procurement Deal To Rid England Of Hepatitis C
Executive Summary
NHS England has struck a “first of its kind” agreement with Gilead, AbbVie and MSD to try to eliminate hepatitis C under which the companies will seek out patients who do not yet know they have the virus.
You may also be interested in...
Looking Beyond The Deal In England
Agreement of deals that promise better value for money and enhanced patient access to new treatments has become routine in England, but are they delivering?
Vertex Finally Inks Orkambi Deal In England
Vertex has finally managed to reach an agreement to bring its cystic fibrosis drugs Orkambi and Symkevi to patients in England, which constitutes an important slice of what is the second biggest market for the drugs.
At Last: Vertex Strikes CF Deal In England
After years of stalemate, NHS England and Vertex have finally agreed a deal that will see cystic fibrosis patients access Orkambi and Symkevi as well as allow more patients to benefit from Kalydeco.